M. A. Gimbrone and G. Garcia-cardena, Endothelial cell dysfunction and the pathobiology of atherosclerosis, Circ Res, vol.118, issue.4, pp.620-656, 2016.

P. Libby, P. M. Ridker, and G. K. Hansson, Progress and challenges in translating the biology of atherosclerosis, Nature, vol.473, issue.7347, pp.317-342, 2011.

A. F. Dominiczak, S. Herget-rosenthal, and C. Delles, Systems biology to battle vascular disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and transplant association, European Renal Association, vol.25, issue.4, pp.1019-1041, 2010.

J. Shalhoub, M. B. Sikkel, K. J. Davies, P. A. Vorkas, E. J. Want et al., Systems biology of human atherosclerosis, Vasc Endovascular Surg, vol.48, issue.1, pp.5-17, 2014.

M. Mokou, V. Lygirou, A. Vlahou, and H. Mischak, Proteomics in cardiovascular disease: recent progress and clinical implication and implementation, Expert Review of Proteomics, vol.14, issue.2, pp.117-153, 2017.

M. Martin-lorenzo, L. Gonzalez-calero, and A. S. Maroto, Cytoskeleton deregulation and impairment in amino acids and energy metabolism in early atherosclerosis at aortic tissue with reflection in plasma, Biochim Biophys Acta, vol.1862, issue.4, pp.725-757, 2016.

M. Martin-lorenzo, I. Zubiri, and A. S. Maroto, KLK1 and ZG16B proteins and arginineproline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recovery, Metabolomics, vol.11, issue.5, pp.1056-67, 2015.

D. M. Herrington, C. Mao, and S. J. Parker, Proteomic architecture of human coronary and aortic atherosclerosis, Circulation, vol.137, issue.25, pp.2741-56, 2018.

E. Veseli, B. Perrotta, P. , D. Meyer, and G. , Animal models of atherosclerosis, Eur J Pharmacol, vol.816, pp.3-13, 2017.

J. S. Saulnier-blache, R. Wilson, and K. Klavins, Ldlr ?/? and ApoE ?/? mice better mimic the human metabolite signature of increased carotid intima media thickness compared to other animal models of cardiovascular disease, Atherosclerosis, vol.276, pp.140-147, 2018.

J. A. Beckman and M. A. Creager, Vascular complications of diabetes, Circ Res, vol.118, issue.11, pp.1771-85, 2016.

X. Shen and K. E. Bornfeldt, Mouse models for studies of cardiovascular complications of type 1 diabetes, Ann N Y Acad Sci, vol.1103, pp.202-219, 2007.

G. S. Getz and C. A. Reardon, Do the Apoe?/? and Ldlr?/? mice yield the same insight on Atherogenesis?, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.36, issue.9, pp.1734-1775, 2016.

V. Lygirou, A. Latosinska, and M. Makridakis, Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease, J Transl Med, vol.16, issue.1, p.104, 2018.

M. Makridakis and A. Vlahou, GeLC-MS: a sample preparation method for proteomics analysis of minimal amount of tissue, Methods Mol Biol, vol.1788, pp.165-75, 2018.

A. Latosinska, M. Mokou, and M. Makridakis, Proteomics analysis of bladder cancer invasion: targeting EIF3D for therapeutic intervention, Oncotarget, vol.8, issue.41, pp.69435-55, 2017.

S. Babicki, D. Arndt, and A. Marcu, Heatmapper: web-enabled heat mapping for all, Nucleic Acids Res, vol.44, issue.W1, pp.147-53, 2016.

A. Kramer, J. Green, J. Pollard, and S. Tugendreich, Causal analysis approaches in ingenuity pathway analysis, Bioinformatics, vol.30, issue.4, pp.523-553, 2014.

G. R. Geovanini and P. Libby, Atherosclerosis and inflammation: overview and updates, Clin Sci, vol.132, issue.12, pp.1243-52, 2018.

G. J. Koelwyn, E. M. Corr, E. Erbay, and K. J. Moore, Regulation of macrophage immunometabolism in atherosclerosis, Nat Immunol, vol.19, issue.6, pp.526-563, 2018.

U. Forstermann, N. Xia, and H. Li, Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis, Circ Res, vol.120, issue.4, pp.713-748, 2017.

J. I. Borissoff, H. M. Spronk, and H. Ten-cate, The hemostatic system as a modulator of atherosclerosis, N Engl J Med, vol.364, issue.18, pp.1746-60, 2011.

Y. Jr, A. Finney, A. C. Woolard, M. D. Orr, and A. W. , The arterial microenvironment: the where and why of atherosclerosis, Biochem J, vol.473, issue.10, pp.1281-95, 2016.

N. Khyzha, A. Alizada, M. D. Wilson, and J. E. Fish, Epigenetics of atherosclerosis: emerging mechanisms and methods, Trends Mol Med, vol.23, issue.4, pp.332-379, 2017.

E. A. Ivanova and A. N. Orekhov, The role of endoplasmic reticulum stress and unfolded protein response in atherosclerosis, Int J Mol Sci, vol.17, issue.2, 2016.

A. Cai, Y. Zhou, and L. Li, Rho-GTPase and atherosclerosis: pleiotropic effects of statins, J Am Heart Assoc, vol.4, issue.7, 2015.

B. E. Rolfe, N. F. Worth, C. J. World, J. H. Campbell, and G. R. Campbell, Rho and vascular disease, Atherosclerosis, vol.183, issue.1, pp.1-16, 2005.

A. C. Finney, K. Y. Stokes, C. B. Pattillo, and A. W. Orr, Integrin signaling in atherosclerosis. Cellular and molecular life sciences, CMLS, vol.74, issue.12, pp.2263-82, 2017.

M. G. Lee, J. Norman, A. Shilatifard, and R. Shiekhattar, Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein, Cell, vol.128, issue.5, pp.877-87, 2007.

S. Fraineau, C. G. Palii, D. S. Allan, and M. Brand, Epigenetic regulation of endothelial-cellmediated vascular repair, FEBS J, vol.282, issue.9, pp.1605-1634, 2015.

K. M. Harmeyer, N. D. Facompre, M. Herlyn, and D. Basu, JARID1 histone demethylases: emerging targets in cancer, Trends in Cancer, vol.3, issue.10, pp.713-738, 2017.

J. R. Horton, X. Liu, and M. Gale, Structural basis for KDM5A histone lysine Demethylase inhibition by diverse compounds, Cell Chemical Biology, vol.23, issue.7, pp.769-81, 2016.

C. Johansson, S. Velupillai, and A. Tumber, Structural analysis of human KDM5B guides histone demethylase inhibitor development, Nat Chem Biol, vol.12, issue.7, pp.539-584, 2016.

A. M. Goodwin, In vitro assays of angiogenesis for assessment of angiogenic and antiangiogenic agents, Microvasc Res, vol.74, issue.2-3, pp.172-83, 2007.

G. S. Getz and C. A. Reardon, Animal models of atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.5, pp.1104-1119, 2012.

M. Scheidt, Y. Zhao, and Z. Kurt, Applications and limitations of mouse models for understanding human atherosclerosis, Cell Metab, vol.25, issue.2, pp.248-61, 2017.

C. F. Zhao and D. M. Herrington, The function of cathepsins B, D, and X in atherosclerosis, American Journal of Cardiovascular Disease, vol.6, issue.4, pp.163-70, 2016.

S. K. Shukla, W. Liu, and K. Sikder, HMGCS2 is a key ketogenic enzyme potentially involved in type 1 diabetes with high cardiovascular risk, Sci Rep, vol.7, issue.1, p.4590, 2017.

P. Srikakulapu, D. Hu, and C. Yin, Artery tertiary lymphoid organs control multilayered territorialized atherosclerosis B-cell responses in aged ApoE?/? mice, Arterioscler Thromb Vasc Biol, vol.36, issue.6, pp.1174-85, 2016.

C. Zhang, H. Zhang, and G. Wu, Titin-truncating variants increase the risk of cardiovascular death in patients with hypertrophic cardiomyopathy, Can J Cardiol, vol.33, issue.10, pp.1292-1299, 2017.

D. Gatica, M. Chiong, S. Lavandero, and D. J. Klionsky, Molecular mechanisms of autophagy in the cardiovascular system, Circ Res, vol.116, issue.3, pp.456-67, 2015.

N. Li, S. S. Dhar, and T. Y. Chen, JARID1D is a suppressor and prognostic marker of prostate cancer invasion and metastasis, Cancer Res, vol.76, issue.4, pp.831-874, 2016.

C. Akimoto, H. Kitagawa, T. Matsumoto, and S. Kato, Spermatogenesis-specific association of SMCY and MSH5, Genes to Cells, vol.13, issue.6, pp.623-656, 2008.

W. Wang, L. R. Meadows, and J. M. Den-haan, Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein, Science, vol.269, issue.5230, pp.1588-90, 1995.

R. Kaneda, S. Takada, and Y. Yamashita, Genome-wide histone methylation profile for heart failure, Genes to Cells, vol.14, issue.1, pp.69-77, 2009.

A. B. Stein, T. A. Jones, and T. J. Herron, Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes, J Clin Invest, vol.121, issue.7, pp.2641-50, 2011.

S. Zaidi, M. Choi, and H. Wakimoto, De novo mutations in histone-modifying genes in congenital heart disease, Nature, vol.498, issue.7453, pp.220-223, 2013.

C. Fork, L. Gu, and J. Hitzel, Epigenetic regulation of angiogenesis by JARID1B-induced repression of HOXA5, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.35, issue.7, pp.1645-52, 2015.

M. R. De-vries and P. H. Quax, Plaque angiogenesis and its relation to inflammation and atherosclerotic plaque destabilization, Curr Opin Lipidol, vol.27, issue.5, pp.499-506, 2016.

S. Zhao, Y. Zhong, and X. Fu, H3K4 methylation regulates LPS-induced proinflammatory cytokine expression and release in macrophages, Shock, vol.51, issue.3, pp.401-407, 2019.